|
1
|
Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu
LZ, Sun Y, Lin AH, Liu MZ and Ma J: How does intensity-modulated
radiotherapy versus conventional two-dimensional radiotherapy
influence the treatment results in nasopharyngeal carcinoma
patients? Int J Radiat Oncol Biol Phys. 80:661–668. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen Y, Sun Y, Liang SB, Zong JF, Li WF,
Chen M, Chen L, Mao YP, Tang LL, Guo Y, et al: Progress report of a
randomized trial comparing long-term survival and late toxicity of
concurrent chemoradiotherapy with adjuvant chemotherapy versus
radiotherapy alone in patients with stage III to IVB nasopharyngeal
carcinoma from endemic regions of China. Cancer. 119:2230–2238.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Plaisance-Bonstaff K and Renne R: Viral
miRNAs. Methods Mol Biol. 721:43–66. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zamore PD and Haley B: Ribo-gnome: The big
world of small RNAs. Science. 309:1519–1524. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA and Croce CM: MicroRNA-cancer
connection: The beginning of a new tale. Cancer Res. 66:7390–7394.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ and Hammond SM: A microRNA polycistron as a potential
human oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Krützfeldt J, Rajewsky N, Braich R, Rajeev
KG, Tuschl T, Manoharan M and Stoffel M: Silencing of microRNAs in
vivo with ‘antagomirs’. Nature. 438:685–689. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Elmén J, Lindow A, Silahtaroglu M, Bak M,
Christensen A, Lind-Thomsen M, Hedtjärn M, Hansen HF, Hansen EM,
Straarup EM, et al: Antagonism of microRNA-122 in mice by
systemically administered LNA-antimiR leads to up-regulation of a
large set of predicted target mRNAs in the liver. Nucleic Acids
Res. 36:1153–1162. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Obad S, dos Santos CO, Petri A, Heidenblad
M, Broom O, Ruse C, Fu C, Lindow M, Stenvang J, Straarup EM, et al:
Silencing of microRNA families by seed-targeting tiny LNAs. Nat
Genet. 43:371–378. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Elmén J, Lindow M, Schütz S, Lawrence M,
Petri A, Obad S, Lindholm M, Hedtjärn M, Hansen HF, Berger U, et
al: LNA-mediated microRNA silencing in non-human primates. Nature.
452:896–899. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Agaoglu Yaman F, Kovancilar M, Dizdar Y,
Darendeliler E, Holdenrieder S, Dalay N and Gezer U: Investigation
of miR-21, miR-141, and miR-221 in blood circulation of patients
with prostate cancer. Tumour Biol. 32:583–588. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mateescu B, Batista L, Cardon M, Gruosso
T, de Feraudy Y, Mariani O, Nicolas A, Meyniel JP, Cottu P,
Sastre-Garau X and Mechta-Grigoriou F: miR-141 and miR-200a act on
ovarian tumorigenesis by controlling oxidative stress response. Nat
Med. 17:1627–1635. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zuo QF, Zhang R, Li BS, Zhao YL, Zhuang Y,
Yu T, Gong L, Li S, Xiao B and Zou QM: MicroRNA-141 inhibits tumor
growth and metastasis in gastric cancer by directly targeting
transcriptional co-activator with PDZ-binding motif, TAZ. Cell
Death Dis. 6:e16232015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song LB, Zeng MS, Liao WT, Zhang L, Mo HY,
Liu WL, Shao JY, Wu QL, Li MZ, Xia YF, et al: Bmi-1 is a novel
molecular marker of nasopharyngeal carcinoma progression and
immortalizes primary human nasopharyngeal epithelial cells. Cancer
Res. 66:6225–6232. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dimri M, Carroll JD, Cho JH and Dimri GP:
microRNA-141 regulates BMI1 expression and induces senescence in
human diploid fibroblasts. Cell Cycle. 12:3537–3546. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gormally E, Caboux E, Vineis P and Hainaut
P: Circulating free DNA in plasma or serum as biomarker of
carcinogenesis: Practical aspects and biological significance.
Mutat Res. 635:105–117. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schwarzenbach H, Hoon DS and Pantel K:
Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev
Cancer. 11:426–437. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kosaka N, Iguchi H and Ochiya T:
Circulating microRNA in body fluid: A new potential biomarker for
cancer diagnosis and prognosis. Cancer Sci. 101:2087–2092. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kang K, Peng X, Luo J and Gou D:
Identification of circulating miRNA biomarkers based on global
quantitative real-time PCR profiling. J Anim Sci Biotechnol.
3:42012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu J, Luo H, Liu X, Peng Y, Zhang B, Wang
L, Xu X, Peng X, Li G, Tian W, et al: miR-9 targets CXCR4 and
functions as a potential tumor suppressor in nasopharyngeal
carcinoma. Carcinogenesis. 35:554–563. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu J, He ML, Wang L, Chen Y, Liu X, Dong
Q, Chen YC, Peng Y, Yao KT, Kung HF and Li XP: MiR-26a inhibits
cell growth and tumorigenesis of nasopharyngeal carcinoma through
repression of EZH2. Cancer Res. 71:225–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu N, Tang LL, Sun Y, Cui RX, Wang HY,
Huang BJ, He QM, Jiang W and Ma J: MiR-29c suppresses invasion and
metastasis by targeting TIAM1 in nasopharyngeal carcinoma. Cancer
Lett. 329:181–188. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang LY, Lee Ho-Fun V, Wong AM, Kwong DL,
Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY and Fu L:
MicroRNA-144 promotes cell proliferation, migration and invasion in
nasopharyngeal carcinoma through repression of PTEN.
Carcinogenesis. 34:454–463. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xia H, Cheung WK, Sze J, Lu G, Jiang S,
Yao H, Bian XW, Poon WS, Kung HF and Lin MC: miR-200a regulates
epithelial-mesenchymal to stem-like transition via ZEB2 and
beta-catenin signaling. J Biol Chem. 285:36995–37004. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu N, Jiang N, Guo R, Jiang W, He QM, Xu
YF, Li YQ, Tang LL, Mao YP, Sun Y and Ma J: MiR-451 inhibits cell
growth and invasion by targeting MIF and is associated with
survival in nasopharyngeal carcinoma. Mol Cancer. 12:1232013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yi C, Wang Q, Wang L, Huang Y, Li L, Liu
L, Zhou X, Xie G, Kang T, Wang H, et al: MiR-663, a microRNA
targeting p21(WAF1/CIP1), promotes the proliferation and
tumorigenesis of nasopharyngeal carcinoma. Oncogene. 31:4421–4433.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qin L, Zhang X, Zhang L, Feng Y, Weng GX,
Li MZ, Kong QL, Qian CN, Zeng YX, Zeng MS, et al: Downregulation of
BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal
carcinoma cells. Biochem Biophys Res Commun. 371:531–535. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Alajez NM, Shi W, Hui AB, Yue S, Ng R, Lo
KW, Bastianutto C, O'Sullivan B, Gullane P and Liu FF: Targeted
depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis
in response to radiation therapy. Cell Death Differ. 16:1469–1479.
2009. View Article : Google Scholar : PubMed/NCBI
|
